BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19727727)

  • 21. DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies.
    Seidl S; Ackermann J; Kaufmann H; Keck A; Nösslinger T; Zielinski CC; Drach J; Zöchbauer-Müller S
    Cancer; 2004 Jun; 100(12):2598-606. PubMed ID: 15197802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas.
    Baur AS; Shaw P; Burri N; Delacrétaz F; Bosman FT; Chaubert P
    Blood; 1999 Sep; 94(5):1773-81. PubMed ID: 10477703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different prognostic values of p15(INK4b) and p16(INK4a) gene methylations in multiple myeloma.
    Guillerm G; Depil S; Wolowiec D; Quesnel B
    Haematologica; 2003 Apr; 88(4):476-8. PubMed ID: 12681979
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
    Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
    Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
    Kawamata N; Inagaki N; Mizumura S; Sugimoto KJ; Sakajiri S; Ohyanagi-Hara M; Oshimi K
    Eur J Haematol; 2005 May; 74(5):424-9. PubMed ID: 15813917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
    Klangby U; Okan I; Magnusson KP; Wendland M; Lind P; Wiman KG
    Blood; 1998 Mar; 91(5):1680-7. PubMed ID: 9473234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16(INK4a) and p15(INK4b) cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells.
    Muscarella P; Knobloch TJ; Ulrich AB; Casto BC; Moniaux N; Wittel UA; Melvin WS; Pour PM; Song H; Gold B; Batra SK; Weghorst CM
    Gene; 2001 Oct; 278(1-2):235-43. PubMed ID: 11707341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.
    Destro A; Ceresoli GL; Baryshnikova E; Garassino I; Zucali PA; De Vincenzo F; Bianchi P; Morenghi E; Testori A; Alloisio M; Santoro A; Roncalli M
    Lung Cancer; 2008 Mar; 59(3):369-76. PubMed ID: 17920725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of CpG island of p14(ARK), p15(INK4b) and p16(INK4a) genes in coke oven workers.
    Zhang H; Li X; Ge L; Yang J; Sun J; Niu Q
    Hum Exp Toxicol; 2015 Feb; 34(2):191-7. PubMed ID: 24837742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease.
    Zhuang J; Peng W; Li H; Wang W; Wei Y; Li W; Xu Y
    PLoS One; 2012; 7(10):e47193. PubMed ID: 23091611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.
    Yoshino A; Katayama Y; Ogino A; Watanabe T; Yachi K; Ohta T; Komine C; Yokoyama T; Fukushima T
    J Neurooncol; 2007 Jun; 83(2):153-62. PubMed ID: 17216555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Abnormality of p15(INK4b) gene and myelodysplastic syndrome].
    Wang Z; Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):362-5. PubMed ID: 12513775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
    Quesnel B; Guillerm G; Vereecque R; Wattel E; Preudhomme C; Bauters F; Vanrumbeke M; Fenaux P
    Blood; 1998 Apr; 91(8):2985-90. PubMed ID: 9531610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.